Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Agah Ramtin
Chief Medical Officer at RenovoRx. Filing since 7 Jun 2022.
CIK 0001862617
Company
Date
Role
Action
Shares
Amount
Of holding
RNXT
RenovoRx, Inc.
21 Jan 2026
Chief Medical Officer
Bought
10,000
$9.98K
1.3%
RNXT
RenovoRx, Inc.
31 Dec 2025
Chief Medical Officer
Bought
9,795
$8.42K
1.3%
RNXT
RenovoRx, Inc.
30 Dec 2025
Chief Medical Officer
Bought
205
$169.33
0.0%
RNXT
RenovoRx, Inc.
16 Dec 2025
Chief Medical Officer
Bought
12,000
$10.20K
1.6%
RNXT
RenovoRx, Inc.
5 Dec 2025
Chief Medical Officer
Bought
10,000
$9.60K
1.3%
RNXT
RenovoRx, Inc.
24 Nov 2025
Chief Medical Officer
Bought
12,000
$9.60K
1.6%
RNXT
RenovoRx, Inc.
21 Nov 2025
Chief Medical Officer
Bought
10,000
$8.00K
1.4%
RNXT
RenovoRx, Inc.
5 Jun 2025
Chief Medical Officer
Bought
21,000
$29.40K
2.9%
RNXT
RenovoRx, Inc.
15 Apr 2025
Chief Medical Officer
Bought
15,000
$13.50K
1.4%
RNXT
RenovoRx, Inc.
11 Apr 2025
Chief Medical Officer
Bought
20,000
$16.00K
1.9%
RNXT
RenovoRx, Inc.
9 Apr 2025
Chief Medical Officer
Bought
30,000
$24.40K
2.9%
RNXT
RenovoRx, Inc.
8 Apr 2025
Chief Medical Officer
Bought
26,000
$21.84K
2.5%
RNXT
RenovoRx, Inc.
26 Jan 2024
Chief Medical Officer
Bought
40,983
no price
633%
RNXT
RenovoRx, Inc.
7 Jun 2022
Chief Medical Officer
Bought
5,182
$10.00K
400%
14 decisions on file.